Search Results - "BAEYENS, V"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Efficacy of 0.18% hypotonic sodium hyaluronate ophthalmic solution in the treatment of signs and symptoms of dry eye disease by Baeyens, V., Bron, A., Baudouin, C.

    Published in Journal francais d'ophtalmologie (01-06-2012)
    “…To compare the safety and efficacy of hypotonic 0.18% sodium hyaluronate solution (0.18% SH) versus saline and versus 0.3% carbomer for the treatment of signs…”
    Get full text
    Journal Article
  2. 2

    Clinical evaluation of bioadhesive ophthalmic drug inserts (BODI ®) for the treatment of external ocular infections in dogs by Baeyens, V, Felt-Baeyens, O, Rougier, S, Pheulpin, S, Boisramé, B, Gurny, R

    Published in Journal of controlled release (13-12-2002)
    “…In the case of external ocular diseases such as conjunctivitis, keratoconjunctivitis sicca (KCS) and superficial corneal ulcers, topical administration of…”
    Get full text
    Journal Article
  3. 3

    A poly(ortho ester) designed for combined ocular delivery of dexamethasone sodium phosphate and 5-fluorouracil: subconjunctival tolerance and in vitro release by Zignani, M, Einmahl, S, Baeyens, V, Varesio, E, Veuthey, J.L, Anderson, J, Heller, J, Tabatabay, C, Gurny, R

    “…A viscous hydrophobic poly(ortho ester) (POE) has been developed as a biocompatible, biodegradable sustained release system for selected cases of glaucoma…”
    Get full text
    Journal Article
  4. 4

    Optimized release of dexamethasone and gentamicin from a soluble ocular insert for the treatment of external ophthalmic infections by Baeyens, V, Kaltsatos, V, Boisramé, B, Varesio, E, Veuthey, J.-L, Fathi, M, Balant, L.P, Gex-Fabry, M, Gurny, R

    Published in Journal of controlled release (02-03-1998)
    “…In the case of external ophthalmic infections, repeated instillations of antibiotics are required to reach therapeutic level, above the minimal inhibitory…”
    Get full text
    Journal Article
  5. 5

    Delivery of antibiotics to the eye using a positively charged polysaccharide as vehicle by Felt, O, Baeyens, V, Buri, P, Gurny, R

    Published in AAPS PharmSci (01-01-2001)
    “…The positively charged polysaccharide chitosan is able to increase precorneal residence time of ophthalmic formulations containing active compounds when…”
    Get full text
    Journal Article
  6. 6

    Determination of dexamethasone in tears by capillary electrophoresis by Baeyens, V., Varesio, E., Veuthey, J.-L., R. Gurny

    “…A selective capillary zone electrophoresis (CZE) microassay was developed for the simultaneous determination of dexamethasone phosphate and its major…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Ocular drug delivery in veterinary medicine by Baeyens, Vincent, Percicot, Christine, Zignani, Monia, Deshpande, Arati A, Kaltsatos, Vassilios, Gurny, Robert

    Published in Advanced drug delivery reviews (08-12-1997)
    “…This paper provides a comprehensive overview of the various approaches currently used in the development of ocular drug delivery systems for the treatment of…”
    Get full text
    Journal Article
  9. 9

    Chemical and physical parameters of tears relevant for the design of ocular drug delivery formulations by Baeyens, Vincent, Gurny, Robert

    Published in Pharmaceutica Acta Helvetiae (01-09-1997)
    “…This paper provides a summary of the most important chemical and physical parameters of tears that can help the formulator in the development of new ocular…”
    Get full text
    Book Review Journal Article
  10. 10
  11. 11

    Evaluation of soluble Bioadhesive Ophthalmic Drug Inserts (BODI) for prolonged release of gentamicin: lachrymal pharmacokinetics and ocular tolerance by Baeyens, V, Kaltsatos, V, Boisrame, B, Fathi, M, Gurny, R

    “…The purpose of this investigation was the evaluation of Bioadhesive Ophthalmic Drug Inserts (BODI) for prolonged release of gentamicin sulfate (GS) in tears…”
    Get more information
    Journal Article
  12. 12
  13. 13
  14. 14